Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Free Cash Flow Generation Index
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Free Cash Flow Generation Index of -0.07x as of September 2025. Free cash flow of CN¥-1.04 Million represents 0% of operating cash flow (CN¥15.48 Million). Read debt load of Zhejiang Hisoar Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Hisoar Pharmaceutical Co Ltd Free Cash Flow Generation Index (2004–2024)
Historical FCF Generation Index trend for Zhejiang Hisoar Pharmaceutical Co Ltd across 21 annual periods. Explore Zhejiang Hisoar Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Zhejiang Hisoar Pharmaceutical Co Ltd (2004–2024)
Year-by-year Free Cash Flow Generation Index for Zhejiang Hisoar Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Hisoar Pharmaceutical Co Ltd (002099) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.30x | CN¥52.73 Million | CN¥174.83 Million | CN¥122.11 Million | ▼ -17.1% |
| 2023 | 0.36x | CN¥87.46 Million | CN¥240.54 Million | CN¥153.08 Million | ▲ +166.7% |
| 2022 | -0.55x | CN¥-63.33 Million | CN¥116.09 Million | CN¥179.42 Million | ▲ +56.1% |
| 2021 | -1.24x | CN¥-127.20 Million | CN¥102.36 Million | CN¥229.56 Million | ▼ -244.3% |
| 2020 | 0.86x | CN¥459.69 Million | CN¥533.87 Million | CN¥74.18 Million | ▲ +16.7% |
| 2019 | 0.74x | CN¥451.76 Million | CN¥612.40 Million | CN¥160.64 Million | ▲ +9.0% |
| 2018 | 0.68x | CN¥535.67 Million | CN¥791.45 Million | CN¥255.78 Million | ▲ +250.0% |
| 2017 | -0.45x | CN¥-46.32 Million | CN¥102.68 Million | CN¥148.99 Million | ▼ -156.2% |
| 2016 | 0.80x | CN¥505.10 Million | CN¥629.42 Million | CN¥124.31 Million | ▲ +123.7% |
| 2015 | 0.36x | CN¥165.81 Million | CN¥462.16 Million | CN¥296.36 Million | ▲ +205.4% |
| 2014 | 0.12x | CN¥22.50 Million | CN¥191.56 Million | CN¥169.06 Million | ▲ +103.2% |
| 2013 | -3.63x | CN¥-220.94 Million | CN¥60.85 Million | CN¥281.79 Million | ▼ -166.7% |
| 2012 | -1.36x | CN¥-246.06 Million | CN¥180.73 Million | CN¥426.79 Million | ▼ -1.0% |
| 2011 | -1.35x | CN¥-124.91 Million | CN¥92.62 Million | CN¥217.52 Million | ▼ -809.6% |
| 2010 | 0.19x | CN¥34.37 Million | CN¥180.88 Million | CN¥146.51 Million | ▼ -58.3% |
| 2009 | 0.46x | CN¥44.78 Million | CN¥98.38 Million | CN¥53.60 Million | ▲ +123.3% |
| 2008 | -1.95x | CN¥-59.80 Million | CN¥30.61 Million | CN¥90.40 Million | ▼ -62.5% |
| 2007 | -1.20x | CN¥-61.47 Million | CN¥51.14 Million | CN¥112.61 Million | ▼ -82.7% |
| 2006 | -0.66x | CN¥-40.70 Million | CN¥61.88 Million | CN¥102.59 Million | ▲ +37.0% |
| 2005 | -1.04x | CN¥-37.67 Million | CN¥36.07 Million | CN¥73.74 Million | ▼ -24454.1% |
| 2004 | 0.00x | CN¥-180.15K | CN¥42.36 Million | CN¥42.54 Million | — |